top of page
AndreTaxCo Logo, Navy Blue on Transparent

AI Agentic Agent R&D Activities and IRC 174A & IRC 174 Reporting and IRC 41 Eligibility

Artificial intelligence (AI) continues to transform industries, driving innovation and creating new opportunities for businesses. Among the most promising developments are AI agentic agents—autonomous systems capable of making decisions and performing tasks independently. These technologies require significant research and development (R&D) efforts, which can qualify for valuable tax incentives under U.S. tax law. Understanding how to properly report these activities under Internal Revenue Code (IRC) Sections 174A and 174, as well as determining eligibility for the IRC 41 credit, is essential for businesses investing in AI.


This article explores the nature of AI agentic agent R&D activities, the requirements for IRC 174A and IRC 174 reporting, and how to assess eligibility for the IRC 41 research credit. It also highlights practical examples of tools that can assist businesses in managing these complex tax matters.


Understanding AI Agentic Agent R&D Activities


AI agentic agents are software systems designed to operate autonomously, making decisions based on data inputs and learned experiences. These agents are used in various applications, including robotics, autonomous vehicles, virtual assistants, and complex decision-making systems.


Developing such agents involves multiple stages of R&D:


  • Conceptual design and algorithm development: Creating the core logic and decision-making frameworks.

  • Data collection and training: Gathering and processing large datasets to train machine learning models.

  • Testing and validation: Running simulations and real-world tests to ensure reliability and safety.

  • Integration and deployment: Embedding the agent into operational environments and refining performance.


Each of these stages requires technical expertise, experimentation, and iteration, which are key factors in qualifying for R&D tax incentives.


IRC §174 and New IRC §174A: Research and Experimental Expenditure Reporting After OBBBA


The federal tax treatment of research and experimental expenditures changed significantly under the One Big Beautiful Bill Act, enacted as Public Law 119-21 on July 4, 2025. The Act amended IRC §174 and added new IRC §174A, creating different rules for domestic and foreign research or experimental expenditures. Rev. Proc. 2025-28 provides important procedural guidance for implementing these changes, including elections, amended or superseding returns, and accounting method changes.


Background: The 2022–2024 TCJA Rules

  • For tax years beginning after December 31, 2021, and before January 1, 2025, the Tax Cuts and Jobs Act rules under former §174 generally required taxpayers to capitalize specified research or experimental expenditures and amortize them over five years for domestic research or 15 years for foreign research. Software development costs were included within these rules.

  • This created a significant cash-tax burden for many businesses, particularly technology, software, life sciences, engineering, and other innovation-driven companies that historically expected current deductions for research and development spending.


What Changed Under OBBBA

  • OBBBA generally restores current deductibility for domestic research or experimental expenditures for tax years beginning after December 31, 2024, through new IRC §174A. Under §174A, taxpayers may generally deduct domestic research or experimental expenditures paid or incurred in connection with a trade or business. Taxpayers may also elect to capitalize and amortize domestic research or experimental expenditures over a period of not less than 60 months, beginning with the month in which the taxpayer first realizes benefits from the expenditures.

  • By contrast, foreign research or experimental expenditures remain subject to capitalization and 15-year amortization under amended §174. This means taxpayers must continue to distinguish carefully between domestic and foreign research activities when preparing federal income tax returns.


Domestic vs. Foreign R&E Treatment

Domestic R&E: For tax years beginning after December 31, 2024, domestic R&E expenditures may generally be deducted currently under new §174A. This is a significant change from the 2022–2024 TCJA regime, which required five-year amortization for domestic specified research or experimental expenditures.


Taxpayers may still need to evaluate whether to deduct domestic R&E currently or elect capitalization and amortization, depending on taxable income, net operating loss considerations, the §41 research credit, §280C adjustments, state tax conformity, and other tax attributes.


Foreign R&E: Foreign R&E expenditures continue to be capitalized and amortized over 15 years. The OBBBA changes did not restore current expensing for foreign research. As a result, taxpayers with offshore engineering, development, software, clinical, testing, or technical teams should continue tracking foreign R&E separately from domestic R&E.


The differing treatment of domestic and foreign R&E may affect decisions about where research activities are performed, how contractor arrangements are structured, and how software development or technical project costs are documented.


Transition Rules for 2022–2024 Domestic R&E

OBBBA and Rev. Proc. 2025-28 provide transition relief for certain domestic R&E expenditures that were capitalized under the TCJA rules for tax years beginning after December 31, 2021, and before January 1, 2025. Rev. Proc. 2025-28 provides procedures for elections, amended or superseding returns, and accounting method changes related to §§174, 174A, and 280C.


Eligible small business taxpayers may be able to make a retroactive election to apply §174A to tax years beginning after December 31, 2021. For 2025, the small business gross receipts threshold is generally described as $31 million, subject to the applicable §448(c) aggregation and tax shelter rules.


For certain small business taxpayers seeking retroactive relief, amended returns generally must be filed by July 6, 2026, or by the applicable §6511 statute-of-limitations deadline, if earlier. Therefore, the July 6, 2026 date should not be treated as a universal deadline for all taxpayers; it is most relevant to the specific retroactive small-business election framework under Rev. Proc. 2025-28.


Taxpayers that do not qualify for, or do not choose, retroactive small-business treatment may still need to evaluate available transition options, including accounting method changes or elections to accelerate remaining unamortized domestic R&E amounts from the 2022–2024 period.


Interaction With the Research Credit and §280C

Businesses claiming the §41 research credit should also consider the interaction between R&E deductions and §280C. OBBBA modified §280C, and Rev. Proc. 2025-28 provides procedures related to §280C elections and related method changes. The treatment of R&E deductions and research credits should be modeled together, rather than analyzed separately.


In practical terms, a company that claims the research credit should coordinate its R&E expense treatment, research credit computation, §280C election position, and any amended-return or method-change strategy before filing.


Practical Reporting Considerations

For AI agentic agent development, this means that costs related to software development, data acquisition, and testing must be carefully tracked and reported according to these rules to optimize tax benefits and ensure compliance.


Taxpayers should maintain contemporaneous records that identify:

  • Maintain detailed records of all R&D activities, including project descriptions, timelines, and expenditures;

  • Separate costs that qualify as R&D from other operational expenses;

  • The nature of the research or experimental activity;

  • Whether the activity was performed in the United States or outside the United States;

  • The business component, product, process, software, platform, formula, invention, or technology involved;

  • The wage, contractor, cloud-computing, supplies, testing, prototype, and other cost categories associated with the activity;

  • Whether the costs support a §41 research credit claim, a §174A deduction, a §174 foreign R&E amortization amount, or some combination of these items; and

  • Whether any prior-year capitalized domestic R&E amounts from 2022–2024 are eligible for transition relief, amended-return treatment, or accounting method change procedures under Rev. Proc. 2025-28;

  • Consult with tax professionals to ensure proper application of amortization rules and avoid errors that could trigger audits.


Because software development remains within the R&E framework, companies developing internal-use software, SaaS platforms, AI tools, automation systems, agentic AI workflows, or other technical platforms should continue tracking software development costs carefully. Software development costs are specifically referenced as included within the §174/§174A R&E framework.


Eye-level view of a computer screen displaying AI code and data analytics
Eye-level view of a computer screen displaying AI code and data analytics

Eye-level view of a computer screen displaying AI code and data analytics during agent development



Eligibility for IRC 41 Research Credit


The IRC 41 research credit provides a dollar-for-dollar reduction in tax liability for qualified research expenses (QREs). This credit is particularly valuable for companies investing heavily in AI R&D.


Criteria for Qualified Research Expenses


To qualify for the IRC 41 credit, research activities must meet the following:


  • Technological in nature: The research must rely on principles of physical or biological sciences, engineering, or computer science.

  • Elimination of uncertainty: The activity must aim to discover information to eliminate uncertainty about the development or improvement of a product or process.

  • Process of experimentation: The research must involve systematic trial and error, testing hypotheses, or evaluating alternatives.

  • Qualified purpose: The research must relate to a new or improved business component.


AI agentic agent development typically meets these criteria, especially when creating new algorithms or improving autonomous decision-making capabilities.


Types of Expenses That Qualify


  • Wages for employees directly involved in R&D.

  • Supplies used in the research process.

  • Contract research expenses paid to third parties.

  • Costs related to software development and testing.


Calculating and Claiming the Credit


  • Calculate the base amount of QREs using either the regular credit method or the alternative simplified credit method.

  • File IRS Form 6765 to claim the credit.

  • Keep thorough documentation to support the claim, including project descriptions, employee time tracking, and expense records.


Best Practices for Compliance and Maximizing Benefits


To fully benefit from IRC 174A and IRC 41 provisions, businesses should adopt the following practices:


  • Early planning: Identify R&D projects and expenses early in the fiscal year to allocate resources effectively.

  • Detailed documentation: Maintain comprehensive records of all research activities, including objectives, methods, and results.

  • Employee time tracking: Record hours spent on qualified research tasks to support wage expense claims.

  • Regular reviews: Conduct periodic audits of R&D expenses and documentation to ensure compliance.

  • Professional guidance: Work with tax advisors experienced in R&D tax credits and software development projects.


These steps help ensure that AI agentic agent R&D activities are properly reported and that eligible tax credits are claimed without issues.



Navigating the Intersection of AI Innovation and Tax Law


The development of AI agentic agents represents a significant investment in technology and innovation. Properly managing the tax implications of these investments requires a clear understanding of IRC 174A and IRC 174 reporting rules, as well as the criteria for IRC 41 credit eligibility.


By leveraging specialized software tracking tools and specialized tax law and accounting support, businesses can streamline their documentation and reporting processes. This approach supports compliance and helps secure valuable tax benefits that can offset the costs of AI innovation.



Close-up view of a person analyzing AI project data on a tablet
Close-up view of a person analyzing AI project data on a tablet

Close-up view of a person analyzing AI project data on a tablet



AI agentic agent R&D activities require careful planning and precise reporting to meet tax code requirements. By understanding the nuances of IRC 174A and IRC 174, and by confirming eligibility for the IRC 41 credit, businesses can reduce tax liabilities and support ongoing innovation. The integration of dedicated tools enhances accuracy and efficiency, making it easier to navigate complex tax laws and maximize financial benefits.

 
 
 
bottom of page